Cell Reports (Oct 2016)

Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection

  • Marcela Montes de Oca,
  • Rajiv Kumar,
  • Fabian de Labastida Rivera,
  • Fiona H. Amante,
  • Meru Sheel,
  • Rebecca J. Faleiro,
  • Patrick T. Bunn,
  • Shannon E. Best,
  • Lynette Beattie,
  • Susanna S. Ng,
  • Chelsea L. Edwards,
  • Glen M. Boyle,
  • Ric N. Price,
  • Nicholas M. Anstey,
  • Jessica R. Loughland,
  • Julie Burel,
  • Denise L. Doolan,
  • Ashraful Haque,
  • James S. McCarthy,
  • Christian R. Engwerda

DOI
https://doi.org/10.1016/j.celrep.2016.09.015
Journal volume & issue
Vol. 17, no. 2
pp. 399 – 412

Abstract

Read online

The development of immunoregulatory networks is important to prevent disease. However, these same networks allow pathogens to persist and reduce vaccine efficacy. Here, we identify type I interferons (IFNs) as important regulators in developing anti-parasitic immunity in healthy volunteers infected for the first time with Plasmodium falciparum. Type I IFNs suppressed innate immune cell function and parasitic-specific CD4+ T cell IFNγ production, and they promoted the development of parasitic-specific IL-10-producing Th1 (Tr1) cells. Type I IFN-dependent, parasite-specific IL-10 production was also observed in P. falciparum malaria patients in the field following chemoprophylaxis. Parasite-induced IL-10 suppressed inflammatory cytokine production, and IL-10 levels after drug treatment were positively associated with parasite burdens before anti-parasitic drug administration. These findings have important implications for understanding the development of host immune responses following blood-stage P. falciparum infection, and they identify type I IFNs and related signaling pathways as potential targets for therapies or vaccine efficacy improvement.

Keywords